News about Regulation

Torrent Pharmaceuticals Receives EIR from USFDA for Dahej Facility

Torrent Pharmaceuticals Receives EIR from USFDA for Dahej Facility

The Dahej facility was placed under OAI by the USFDA based on the March 2019 Inspection outcome.

Regulation | 25/08/2023 | By Manvi 1611

Glenmark Pharma settles drug pricing case with US Department of Justice

Glenmark Pharma settles drug pricing case with US Department of Justice

Glenmark Pharma settles drug pricing case with US Department of Justice

Regulation | 24/08/2023 | By Sudeep Soparkar 756

Sun Pharma, Alembic recall drugs in US market

Sun Pharma, Alembic recall drugs in US market

Sun Pharma, Alembic recall drugs in US market

Regulation | 22/08/2023 | By Sudeep Soparkar 747

Flawless Pharma Pvt Ltd will spend USD 100 Million in Hong Kong and China Assets & Patents buyout

Flawless Pharma Pvt Ltd will spend USD 100 Million in Hong Kong and China Assets & Patents buyout

Flawless Pharma Pvt Ltd will spend USD 100 Million in Hong Kong and China Assets & Patents buyout

Regulation | 03/08/2023 | By Sudeep Soparkar 1052

Lupin Announces Resolution of US FDA Warning Letter for its Goa and Pithampur Facilities

Lupin Announces Resolution of US FDA Warning Letter for its Goa and Pithampur Facilities

This is after the satisfactory evaluation of the corrective actions taken by the company in response to the Warning Letter that was issued on November 6, 2017.

Regulation | 28/07/2023 | By Manvi 918

Income Tax Survey at Ipca Laboratories Ltd's plants

Income Tax Survey at Ipca Laboratories Ltd's plants

The Income Tax Department has carried out survey proceedings at the Company's offices in Mumbai and at Sikkim manufacturing plants between 30th May, 2023 to 3rd June, 2023.

Regulation | 06/06/2023 | By Sudeep Soparkar 621

US FDA Conducts GMP Inspection at Piramal Pharma's Digwal Facility

US FDA Conducts GMP Inspection at Piramal Pharma's Digwal Facility

The inspection that was held from March 27 to 31 was completed successfully with Zero Form-483 observations.

Regulation | 05/04/2023 | By Manvi 1539

Govt Cancels License of 18 Pharma Companies

Govt Cancels License of 18 Pharma Companies

As many as 76 pharma companies were inspected across 20 states/ UTs by a joint team of the state and central drug regulators.

Regulation | 05/04/2023 | By Manvi 607

Cipla receives EIR for Indore plant

Cipla receives EIR for Indore plant

The inspection was conducted from June 27, 2022, to July 01, 2022.

Regulation | 23/09/2022 | By Sudeep Soparkar 1094

LANXESS value change to become climate-neutral

LANXESS value change to become climate-neutral

Specialty chemicals company LANXESS is taking the next step in climate protection and has set a target for its scope 3 emissions

Regulation | 10/08/2022 | By Sudeep Soparkar 732

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members